Greater change in bone turnover markers for efavirenz/emtricitabine/tenofovir disoproxil fumarate versus dolutegravir + abacavir/lamivudine in antiretroviral therapy-naive adults...

Tebas, Pablo; Kumar, Princy; Hicks, Charles; More

AIDS . 29(18):2459-2464, November 28, 2015.

Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study

Stellbrink, Hans-Jürgen; Reynes, Jacques; Lazzarin, Adriano; More

AIDS . 27(11):1771-1778, July 17, 2013.

Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults

Min, Sherene; Sloan, Louis; DeJesus, Edwin; More

AIDS . 25(14):1737-1745, September 10, 2011.